These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8353085)

  • 1. The relevance of pharmacology in clinical oncology practice. Pharmacology is relevant.
    Gianni L
    Ann Oncol; 1993 Jun; 4(6):463-5. PubMed ID: 8353085
    [No Abstract]   [Full Text] [Related]  

  • 2. The relevance of pharmacology in clinical oncology practice. The moderator thinks that...
    Workman P
    Ann Oncol; 1993 Jun; 4(6):466-9. PubMed ID: 8353087
    [No Abstract]   [Full Text] [Related]  

  • 3. The relevance of pharmacology in clinical oncology practice. Pharmacology is (as yet) no relevant...
    McVie JG
    Ann Oncol; 1993 Jun; 4(6):465. PubMed ID: 8353086
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacometrics and systems biology in oncology: is there an intersection?
    Kloft C
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):89-90. PubMed ID: 23260011
    [No Abstract]   [Full Text] [Related]  

  • 5. The Role of Clinical Pharmacology in Oncology Dose Selection: Advances and Opportunities in Personalized Medicine.
    Shord SS
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S99-S104. PubMed ID: 28921640
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings of the 5th Conference on Oncological Clinical Pharmacology. Reims, France, 8-10 November 1994.
    Anticancer Res; 1994; 14(6A):2267-396. PubMed ID: 7825956
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
    Scholler N
    IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geriatric clinical pharmacologist and medical oncologist: a new partnership?
    Vestal RE; Calabresi P
    Clin Pharmacol Ther; 1997 Oct; 62(4):361-4. PubMed ID: 9357386
    [No Abstract]   [Full Text] [Related]  

  • 10. An interview with Luca Gianni.
    Gianni L
    Lancet; 2010 Jan; 375(9712):367. PubMed ID: 20113815
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring in Oncology.
    Wilkinson DS
    Ther Drug Monit; 2019 Oct; 41(5):551-552. PubMed ID: 31318845
    [No Abstract]   [Full Text] [Related]  

  • 12. On clinical biochemical pharmacology of 5-fluorouracil and anticancer pyrimidines, Marseille, July 22-23, 1978, USA-France agreement in clinical trial and treatment research (NCI-INSERM).
    Bull Cancer; 1979; 66(1):37-100. PubMed ID: 33733
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical pharmacology and immunotherapy, 4th edition of the congress of pharmacology of anticancer drugs].
    de Percin S; Fidelle M; Carton E; Goldwasser F
    Bull Cancer; 2017 Sep; 104(9):807-811. PubMed ID: 28784244
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic drug monitoring in oncology: does it have a future?
    McMahon G; O'Connor R
    Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent developments in the pharmacology of anticancer drugs in the elderly.
    Lichtman SM
    Curr Opin Oncol; 1998 Nov; 10(6):572-9. PubMed ID: 9818238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical practice guidelines for the adverse events in medical oncology].
    Isobe T; Hayashi M; Tsubata Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():45-50. PubMed ID: 25831722
    [No Abstract]   [Full Text] [Related]  

  • 18. New anticancer agents: role of clinical pharmacy services.
    Leveque D; Delpeuch A; Gourieux B
    Anticancer Res; 2014 Apr; 34(4):1573-8. PubMed ID: 24692684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacology and toxicology of anticancer drugs].
    Kato Y; Ando Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():109-13. PubMed ID: 25831733
    [No Abstract]   [Full Text] [Related]  

  • 20. American Society of Clinical Oncology Statement on the Impact of Utilization Management Policies for Cancer Drug Therapies.
    American Society of Clinical Oncology
    J Oncol Pract; 2017 Nov; 13(11):758-762. PubMed ID: 28872996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.